Bioblast Pharma Ltd Stock Nasdaq
Equities
IL0011319527
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 28.22M |
---|---|---|---|---|---|
Net income 2024 * | -16M | Net income 2025 * | -12M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.74
x | P/E ratio 2025 * |
-2.73
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.57% |
Managers | Title | Age | Since |
---|---|---|---|
Oren Hershkovitz
CEO | Chief Executive Officer | 47 | 19-11-15 |
Dror Mevorach
FOU | Founder | 68 | 08-12-31 |
Director of Finance/CFO | 47 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shai Novik
CHM | Chairman | 58 | 19-03-25 |
Avri Havron
BRD | Director/Board Member | 75 | 13-12-31 |
Brian Schwartz
BRD | Director/Board Member | 52 | 20-11-30 |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |